KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Current Deferred Tax Assets: 2010-2015

Historic Current Deferred Tax Assets for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to $88,000.

  • Biocryst Pharmaceuticals' Current Deferred Tax Assets rose 15.79% to $88,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $88,000, marking a year-over-year increase of 15.79%. This contributed to the annual value of $76,000 for FY2014, which is 1.33% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Current Deferred Tax Assets stood at $88,000 for Q3 2015, which was down 12.87% from $101,000 recorded in Q2 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Current Deferred Tax Assets peaked at $2.3 million during Q4 2011, and registered a low of $73,000 during Q3 2013.
  • Its 3-year average for Current Deferred Tax Assets is $79,444, with a median of $76,000 in 2015.
  • In the last 5 years, Biocryst Pharmaceuticals' Current Deferred Tax Assets skyrocketed by 220.03% in 2011 and then crashed by 82.09% in 2012.
  • Biocryst Pharmaceuticals' Current Deferred Tax Assets (Quarterly) stood at $2.3 million in 2011, then slumped by 82.09% to $412,000 in 2012, then tumbled by 81.80% to $75,000 in 2013, then grew by 1.33% to $76,000 in 2014, then increased by 15.79% to $88,000 in 2015.
  • Its Current Deferred Tax Assets stands at $88,000 for Q3 2015, versus $101,000 for Q2 2015 and $76,000 for Q1 2015.